...
首页> 外文期刊>The journal of sexual medicine >The Effect of Statins on Erectile Dysfunction: A Systematic Review and Meta-Analysis
【24h】

The Effect of Statins on Erectile Dysfunction: A Systematic Review and Meta-Analysis

机译:他汀类药物对勃起功能障碍的影响:系统评价和荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction It is not known if statins will improve symptoms in patients with established erectile dysfunction (ED). Aim We carried out a systematic review and meta-analysis to assess the effect of statins on ED. Methods A literature review was performed to identify all published randomized double-blind, placebo-controlled trials of statins for the treatment of ED. The search included the following databases: MEDLINE, Embase, and the Cochrane Controlled Trials Register. The reference lists of the retrieved studies were also investigated. A systematic review and meta-analysis were conducted. Main Outcome Measures Six publications involving a total of 462 patients were used in the analysis, including three randomized controlled trials (RCTs) that compared statins with placebo and three RCTs that compared statins plus sildenafil with placebo plus sildenafil. Results For the comparison of statins (+/- sildenafil) with placebo (+/- sildenafil), the mean International Index of Erectile Function (IIEF-5) (the standardized mean difference [SMD]=3.23, 95% confidence interval [CI]=-1.65 to 4.80, P<0.0001) indicated that statins (+/- sildenafil) showed statistically significantly greater improvements in the mean IIEF-5 compared with placebo (+/- sildenafil). For the comparison of statins with placebo, the mean IIEF-5 (SMD=2.13, 95% CI=-1.46 to 5.73, P=0.24) indicated that there was no significant difference in erectile function between the statins and placebo. For the comparison of statins plus sildenafil with placebo plus sildenafil, the mean IIEF-5 (SMD=3.60, 95% CI=2.64 to 4.56, P<0.00001), the IIEF domain (SMD=4.88, 95%CI=3.01 to 6.74, P<0.00001), and the global efficacy question (odds ratio=6.44, 95% CI=2.92 to 14.23, P<0.00001) showed that compared with placebo plus sildenafil, statins plus sildenafil clearly improved erectile function. Conclusions This meta-analysis indicates that statins (+/- sildenafil) may improve ED compared with placebo (+/- sildenafil). Cui Y, Zong H, Yan H, and Zhang Y. The effect of statins on erectile dysfunction: A systematic review and meta-analysis. J Sex Med 2014;11:1367-1375.
机译:引言目前尚不清楚他汀类药物是否能改善勃起功能障碍(ED)患者的症状。目的我们进行了系统的综述和荟萃分析,以评估他汀类药物对ED的作用。方法进行文献综述,以鉴定所有已发表的他汀类药物治疗ED的随机双盲,安慰剂对照试验。搜索包括以下数据库:MEDLINE,Embase和Cochrane对照试验注册。还对检索到的研究的参考文献清单进行了调查。进行了系统的审查和荟萃分析。主要结果措施分析中使用了六种出版物,涉及462位患者,其中包括将他汀类药物与安慰剂进行比较的三项随机对照试验(RCT),以及将他汀类药物与西地那非与安慰剂联合西地那非进行比较的三项RCT。结果为了比较他汀类药物(+/-西地那非)和安慰剂(+/-西地那非)的平均国际勃起功能指数(IIEF-5)(标准化平均差[SMD] = 3.23,95%置信区间[CI] ] =-1.65至4.80,P <0.0001)表明,与安慰剂(+/-西地那非)相比,他汀类药物(+/-西地那非)在平均IIEF-5方面显示出统计学上显着更大的改善。对于他汀类药物与安慰剂的比较,平均IIEF-5(SMD = 2.13,95%CI = -1.46至5.73,P = 0.24)表明,他汀类药物和安慰剂之间的勃起功能没有显着差异。为了比较他汀类药物加西地那非与安慰剂加西地那非的比较,平均IIEF-5(SMD = 3.60,95%CI = 2.64至4.56,P <0.00001),IIEF域(SMD = 4.88,95%CI = 3.01至6.74 ,P <0.00001)和整体功效问题(赔率= 6.44,95%CI = 2.92至14.23,P <0.00001)显示,与安慰剂加西地那非相比,他汀类药物与西地那非明显改善了勃起功能。结论这项荟萃分析表明,与安慰剂(+/-西地那非)相比,他汀类药物(+/-西地那非)可能改善ED。崔Y,宗红,颜红,张Y。他汀类药物对勃起功能障碍的影响:系统评价和荟萃分析。 J Sex Med 2014; 11:1367-1375。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号